In the News

LithoVue Elite's real-time IRP monitoring may expand ureteroscopy to larger stones, improving patient outcomes by reducing complications like bleeding and sepsis.

Endoscopic sleeve gastroplasty (ESG) is gaining recognition as a minimally invasive and effective treatment for obesity. Endorsed by international and national obesity societies, ESG involves reducing stomach size through internal suturing, leading to significant weight loss with a low rate of serious adverse events. Its less invasive nature compared to traditional bariatric surgery offers advantages such as better tolerance, fewer complications, and quicker recovery times, making it a valuable option for patients with mild to moderate obesity or those seeking alternatives to surgery.

In this episode of the DeviceTalks Weekly Podcast, Vincent Sourdaine, vice president of neuromodulation for EMEA, shares his journey into the MedTech industry and his fascination with neurotechnologies.

"The latest innovations in kidney stone treatment took centre stage at this year’s European Association of Urology (EAU) Congress held in Madrid, among which were the first live procedures from Prof. Skolarikos from Sismanoglio General Hospital of Athens, Greece, using LithoVue Elite Single-Use Digital Flexible Ureteroscope System.

In an interview with Astrid Monteau, EMEA Vice President of Endoscopy, the discussion centers on the growing role of minimally invasive endoscopic procedures in obesity treatment. Monteau emphasizes the importance of innovation in expanding treatment options, like Endoscopic Sleeve Gastroplasty (ESG), to provide effective solutions for obesity management.